it looks like MCO has become a compelling story for someone. if we assume that the buyer/s have a long term view of MCO then a lot of script is being removed from trading over the last week.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%